摘要
用乳化聚合法制备了米托蒽醌聚氰基丙烯酸正丁酯毫微粒,并对其表面荷电特性、形态、大小及其分布、体外释药性质、载药量、初步稳定性和在动物体内的分布进行了研究。结果表明,粒径dav=55.23nm,载药量为46.77%,包封率为84.89%,表面带负电荷。体外释药符合双相动力学规律。其胶体溶液能经受煮沸30min灭菌。经氚标记液闪计数技术测定证实其iv后主要集中于肝脏,并有一定的肝肿瘤和肝细胞的靶向性。提示其对于提高米托蒽醌抗肝癌的效果和降低其全身毒副作用有重要意义。
The mitoxantrone
polybutylcyanoacrylate nanosparticles( DHAQ-PBCA-NP )wereprepared by
emulsion polymerization method. The surface charge,drug
lodaing,morphology, sizeand size distribution, release
characteristics in vitro,stablity and distribution in animals of
DHAQ-PR-CA-NP were studied. The results showed that the mean size
wasdav=55.23 nm,drug loading was46.77%,embedding ratio was 84.89%.
The surface carried negative charge and the release charac-teristics
in vitro was in accord with two phases kinetics law. The colloidal
solution Of DHAQ-PECA-NPcan undergo boilling for 30 min
sterilization. The radiOactivity concentrated mainlv in liver after
iv3H-DHAQ-PBCA-NP. The radioactivity in liver tumor was higher than
that in the liver tissue.DHAQ-PBCA-NP was observed in parenchymal
cell 15 min after iv DHAQ-PBCA-NS.This prepara-tion seems to have
important value for increasing the anti-liver tumor effect and
decreasing the toxicityof DHAQ.
出处
《药学学报》
CAS
CSCD
北大核心
1994年第7期544-549,共6页
Acta Pharmaceutica Sinica
基金
国家自然科学基金
关键词
米托蒽醌
毫微粒
抗癌药
Mitoxantrone
PolycyanoacryLate nanospheres